Department of Cardiovascular Surgery, Hyogo College of Medicine, 1-1 Mukogawa-cho, Nishinomiya, Hyogo, 663-8501, Japan.
J Artif Organs. 2020 Dec;23(4):401-404. doi: 10.1007/s10047-020-01182-z. Epub 2020 Jun 7.
Sutureless aortic valve replacement (AVR) offers an alternative approach to the standard AVR in aortic valve disease. We herein report a case of an 82-year-old woman with severe aortic insufficiency and a persistent type 1 endoleak following a thoracic endovascular aortic repair, who underwent successful combined aortic arch reconstruction and sutureless AVR. The bioprosthesis, Perceval (LivaNova PLC, London, UK), a self-anchoring, self-expanding, sutureless valve, which can be implanted in selected patients with aortic insufficiency was used. Although the patient was frail and at a high risk of open-heart surgery, she had an uneventful postoperative course. Hence, Perceval may be a useful option for combined aortic arch reconstruction and aortic valve surgery in high-risk elderly patients.
经导管主动脉瓣置换术（AVR）为主动脉瓣疾病的标准 AVR 提供了一种替代方法。本文报告了 1 例 82 岁女性，因胸主动脉腔内修复术后持续 1 型内漏伴严重主动脉瓣关闭不全，行成功的主动脉弓重建和无缝线 AVR 联合手术。使用了生物假体 Perceval（LivaNova PLC，伦敦，英国），一种自固定、自扩张、无缝线的瓣膜，可在选定的主动脉瓣关闭不全患者中植入。尽管患者身体虚弱，开胸手术风险高，但术后无并发症。因此，Perceval 可能是高危老年患者主动脉弓重建和主动脉瓣手术的一种有用选择。
